MRI developer Advanced NMR plans to merge with its Advanced MammographySystems subsidiary, of which it presently owns 61%. On completionof the deal, AMS will operate as a wholly owned subsidiary ofAdvanced NMR, of Wilmington, MA. In other Advanced NMR
MRI developer Advanced NMR plans to merge with its Advanced MammographySystems subsidiary, of which it presently owns 61%. On completionof the deal, AMS will operate as a wholly owned subsidiary ofAdvanced NMR, of Wilmington, MA.
In other Advanced NMR news, the company said that it has extendedits contract with GE Medical Systems in which ANMR is the exclusivesystems integrator for GE 3- and 4-tesla research MRI scanners.Each sale of a very-high-field scanner will result in a minimumpayment of $1.5 million to ANMR. The deal extends through 1999.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.